Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Versus Seresta® 10 mg Tablets in Healthy Subjects
Phase 1
- Conditions
- o medical condition is being investigated. This is a comparative bioavailabilty study.MedDRA version: 20.0Level: PTClassification code: 10002855Term: Anxiety Class: 100000004873MedDRA version: 20.0Level: PTClassification code: 10012225Term: Delirium tremens Class: 100000004873Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- CTIS2022-501134-35-00
- Lead Sponsor
- aboratorios Lesvi S.L.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method